NVRO Earnings

NVRO reported its FY2024Q4 earnings on 2025-03-04, showcasing a revenue of 105.55M against an estimate of 102.61M, resulting in a 2.86% surprise. The EPS was -0.64, surpassing the expected -0.79 by 18.99%. The stock experienced a 1.05% price change on the earnings day and a 0.87% change over the next five days, reflecting market reactions to the results.

Following NVRO's FY2024Q4 earnings announcement on 2025-03-04, the stock price moved by 1.05% on the day of the release. Over the subsequent five days, it saw a 0.87% change. Historically, NVRO's stock price tends to shift by an average of 5.12% in the 10 days leading up to earnings and -9.16% in the 10 days following, providing insight into potential market.

For 2024/Q4, analysts estimate NVRO's annual revenue to reach 102.61M, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between NVRO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NVRO's stock price typically moves by 5.12% in the 10 days before its earnings and -9.16% in the 10 days after. For the upcoming 2024/Q4 earnings, analysts expect an EPS of undefined and revenue of 102.61M.

The earnings call reveals several negative indicators: declining revenue and trials in the core SCS market, negative adjusted EBITDA, and reduced 2024 revenue guidance. Despite restructuring efforts and a slight cash increase, competitive pressures persist. The Q&A section highlights management's focus on cost-cutting and strategic investments, but lacks clear quantitative guidance and timelines for improvement. The negative sentiment is reinforced by the weak financial performance and cautious market outlook, suggesting a negative stock price movement of -2% to -8% over the next two weeks.